Phage technology for tumor-targeting drug development is revolutionizing cancer therapy by enabling precise delivery of therapeutic agents to tumor sites. Bacteriophages can be engineered to display peptides that specifically bind to cancer cells, improving drug targeting and reducing off-target effects. This approach enhances the efficacy and safety of treatments like chemotherapy and immunotherapy. Phage technology for tumor-targeting drug development holds great promise for creating personalized and effective cancer therapies, offering new hope for patients with difficult-to-treat malignancies.
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek